About
Diagnostics, ELISA kits
Areas of Focus
Categories
DiagnosticsNon-PharmaceuticalChina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
325
By Phase
PHASE1: 2
By Status
RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05785754Lead Sponsor
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
320 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
NCT05496595Lead Sponsor
DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors
PHASE1Terminated
5 participants
Started: Oct 26, 2022 · Completed: Feb 5, 2024
Locations (1)
Headquarters
Tianjin, China
Map
Loading map...